HSBC Holdings
MRSN

HSBC Holdings’s Mersana Therapeutics MRSN Stock Holding History

HSBC Holdings’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,220
Closed -$8.78K – 2988
2025
Q2 		$8.78K Buy
1,220
+720
+144% +$6.33K ﹤0.01% 2997
2025
Q1 		$4.38K Sell
500
-32
-6% -$494 ﹤0.01% 3003
2024
Q4 		$18.3K Sell
532
-27
-5% -$1.4K ﹤0.01% 3054
2024
Q3 		$25.7K Buy
559
+58
+12% +$2.56K ﹤0.01% 2930
2024
Q2 		$24.9K Sell
501
-3
-0.6% -$217 ﹤0.01% 2864
2024
Q1 		$56.5K Buy
+504
New +$50.1K ﹤0.01% 2927
2022
Q3 		– Sell
-749
Closed -$85K – 3141
2022
Q2 		$85K Buy
+749
New +$70.4K ﹤0.01% 3064

Other funds holding MRSN

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
AV
Alamea Verwaltungs Edison, New Jersey $135M AUM 36.32% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $12.3B AUM 37.17% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $849M AUM 470.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return